A Phase 3, Randomized, Multi-Center, Open-Label Study to

Project: Research project

Description

A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg Formulations in Children with Central Precocious Puberty
StatusFinished
Effective start/end date2/18/0812/31/11

Funding

  • Abbott Laboratories

Fingerprint

Leuprolide
Safety
Central Precocious Puberty